BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2961976)

  • 1. Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine.
    Seeman P; Guan HC
    Mol Pharmacol; 1987 Dec; 32(6):760-3. PubMed ID: 2961976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of dopamine D2 receptors by sodium and pH.
    Neve KA
    Mol Pharmacol; 1991 Apr; 39(4):570-8. PubMed ID: 2017157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB; Guan JH; Neumeyer JL; Seeman P
    Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM; Wooten GF; Trugman JM
    J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the mechanism of apomorphine for treatment of myopia].
    Xiao L; Chen R; Guo J
    Zhonghua Yan Ke Za Zhi; 1998 Mar; 34(2):130-3. PubMed ID: 11877174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT; Matsokis NA; Valcana T
    J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN; Lexow N; Bird E; Winokur A
    Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.
    d'Emmanuele di Villa Bianca R; Sorrentino R; Roviezzo F; Imbimbo C; Palmieri A; De Dominicis G; Montorsi F; Cirino G; Mirone V
    Int J Impot Res; 2005; 17(2):127-33. PubMed ID: 15549138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
    Seeman P
    Synapse; 2007 Dec; 61(12):1013-8. PubMed ID: 17853435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced stereotypic behavior by chronic treatment with bromocriptine accompanies increase of D-1 receptor binding.
    Le WD; Zhou XD; Jin GZ
    Life Sci; 1988; 42(19):1841-5. PubMed ID: 2966885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of dopamine depletion on the distribution of [3H]SCH 23390 and [3H]spiperone binding sites in the goldfish retina.
    Yazulla S; Lin ZS
    Vision Res; 1995 Sep; 35(17):2409-14. PubMed ID: 8594810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.